Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors

摘要

This invention relates to diaminopyrroloquinazoline compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.